About Us

We are a consumer driven, pharma company, devoted to research and development of beneficial products based on our Buccal Extended Release Drug Delivery System.

We develop innovative drug products for treatment of widespread diseases that currently do not have satisfactory solutions. We design our products to optimize their efficiency, their specificity with safety and regulation profiles and optimal patient compliance.

We build upon more than 5 years of R&D by a team of founders with more than 180 combined years of experience in pharmaceutics, organic chemistry and dentistry.

We are embarking on a world changing exciting journey to fulfill our vision and improve people’s lives.

OUR Team

Igal Pikovsky

Founder, CEO

MBA, 25 years of experience as entrepreneur in food development.

2 successful new food product launches.

Specializes in user compliance and consumer decision making.

Highly experienced in operating and managing under high uncertainty.

Experienced in developing new consumer goods concepts and introducing new products to the market.

Prof. Eli Heldman

Partner, Pharmaceutica – Research Supervisor

A member of the Department of Clinical Biochemistry and Pharmacology at Ben Gurion University.

A pharmacologist with more than 40 years experience in developing therapeutic drugs and drug delivery systems.

A co-inventor of EVOXAC, an FDA approved drug for the treatment of Sjogren’s syndrome and a co-founder of NeuroDerm Ltd., (used to be NDRM in NASDAQ), which was sold in 2017 to Mitsubishi Tanabe Pharma for $1.1B.

Dr. Keren Fogel

Head of Research

B.Sc. in Biotechnology;

M.Sc. in plant science from the Faculty of Agriculture, Food and Environment;

Ph.D. in plant science from Ben-Gurion University of the Negev. 10 years’ experience as R&D Senior Scientist in the pharmaceutical industry.

David Tavor

Partner, Investor relations

More than 25 years’ experience as General Manager and founder of Biotech, Pharmaceutical and Medical device companies.

Colgate’s Consultant and its Business Representative in Israel for identifying technologies for acquisition, investment and cooperation.

Served as a Colonel, fighter pilot and a commander in the Israeli Air Force. Holds an MA degree in Political Science and National Defense Studies and MBA studies.

Dr. Santiago Ini

Partner, Chemistry and Cannabis

Organic Chemist expert in innovation in the life science sector. As Director of Life Science of T3 (Tech. transfer office of the Technicon) he set up Companies like Nano-Ghost and Cannasoul.

He is the founder of Mental Heal, a company that develops a drug for the negative symptoms of schizophrenia and Glaucopharm, a company dealing with the treatment for Glaucoma.

Dr. Guy Tobias

Partner, Oral germs and Clinical Trails

BSc. MED in 2005, DMD in 2007, MPH in 2012, Ph.D. In 2020 from the Hebrew University – Faculty of Dentistry in Hadassah. Doctor of Dentistry, research and technology consultant for dental and pharma startups.

Member of the Faculty of Dentistry and Head of Dental Research, Hadassah University. Currently serves as the President of the Israel Society for Public Health in Israel.

Dr. Liat Lomnitski

Partner, Regulation and Toxicology

Expert in the regulation of toxicology. Pre-clinical development and safety assessment of innovative drugs, chemicals and food ingredients.

Over 20 years in the field of regulatory toxicology. Worked in Teva, Agis, Perrigo, Padgis and several Startup companies. Serves as Head of Preclinical Development and Toxicology at Perrigo/Padagis since 2003 to date.